2026
Introduction
- What are current recommendations for treatment of drug extravasation?
- What evidence is available on reducing the dosing interval of extended-release naltrexone for alcohol use disorder?
- What evidence supports the use of lower doses of alteplase (1 to 5 mg) for pleural infection?
- What alternatives to azithromycin can be utilized for antimicrobial prophylaxis during emergent cesarean section delivery?
- Are there data to support the use of lefamulin for pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)?
- What recent evidence is available on the off-label use of phenobarbital for alcohol withdrawal syndrome?
- What evidence is available to support the use of ramelteon for delirium prevention in the hospital/inpatient setting?
- What evidence supports the use of tebipenem pivoxil for treatment of complicated urinary tract infection?
- Update: What evidence is available on the off-label use of dexmedetomidine for alcohol withdrawal syndrome?
- What FDA-approved treatment options are available for triple seronegative myasthenia gravis?
- Is sodium bicarbonate an acceptable lock solution for patients receiving parenteral nutrition?
- What evidence supports the use of apolipoprotein C3 (APOC3) inhibitors for familial chylomicronemia syndrome (FCS)?
- What are current recommendations for prevention and treatment of post-operative nausea and vomiting (PONV)?
- What are key updates from the 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on dyslipidemia management?
- What evidence supports the use of the oral GLP-1 receptor agonist orforglipron for obesity?
- What evidence supports the use of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) for management of anemia in chronic kidney disease (CKD)?
- How long should antibiotics be continued following an amputation for diabetic foot infection, particularly in cases of residual bone infection?
- Update: What are Major Pharmacotherapy Updates from the 2026 AHA/ASA Stroke Guidelines?
- What is the role of oral semaglutide (Wegovy) in weight loss for patients who are overweight or obese?
- What is the most recent information on managing MASLD/MASH in pediatric and adolescent patients?
- What information is available on the use and dosing of tranexamic acid (TXA) for major trauma?
- Is there evidence to support alternate-day dosing of oral iron for the treatment of iron deficiency anemia?
- What are current recommendations on the screening and management of hepatitis B infection in pregnancy?
- What Are the Latest Recommendations for Occupational HIV Post-Exposure Prophylaxis in Healthcare Settings?
- What data is available to support the use of neurokinin 3 (NK3) receptor antagonists for the management of vasomotor symptoms related to menopause?
- What literature is available to support the use of brensocatib in individuals with bronchiectasis?
- What is the role of insulin infusion in hypertriglyceridemia-induced acute pancreatitis?